Honeywell International Inc. is exploring a separation of its aerospace business as the industrial company faces calls from activist Elliott Investment Management for a breakup.
L’Oreal SA is buying a 10% stake in Galderma Group AG, a Swiss maker of injectable skin fillers, with the two agreeing to collaborate on new products to reduce the signs of aging.
Remy Cointreau SA sales slumped in the first quarter of its fiscal year as the Cognac maker suffered from falling demand in the US and tougher markets in Southeast Asia.
Eli Lilly & Co. agreed to buy U.S. biopharma company Morphic Holding Inc. for about $3.2 billion to gain experimental therapies for inflammatory bowel disease and other chronic illnesses.
Becton Dickinson & Co. agreed to buy the critical care unit of Edwards Lifesciences Corp. for $4.2 billion in cash to expand its range of medical monitoring products.
Michelin jumped the most in almost two years after the French tiremaker reported solid earnings and announced a plan to buy back up to €1 billion ($1.1 billion) of stock.
Just over a year after China ended its Covid-Zero policy, the expected bounceback in spending on high-end consumer goods has failed to live up to expectations.
Britain’s regulator became the first in the world to approve Merck & Co.’s Covid-19 antiviral pill, describing the treatment as safe and effective following a swift review.